KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Retained Earnings (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Retained Earnings for 17 consecutive years, with $8.2 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 1619.19% to $8.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 billion through Dec 2025, up 1619.19% year-over-year, with the annual reading at $8.2 billion for FY2025, 1619.19% up from the prior year.
  • Retained Earnings for Q4 2025 was $8.2 billion at Bio-Rad Laboratories, up from -$166.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $8.2 billion in Q4 2025, with the low at -$823.8 million in Q3 2022.
  • Average Retained Earnings over 5 years is $948.8 million, with a median of -$251.4 million recorded in 2023.
  • The sharpest move saw Retained Earnings tumbled 8148.28% in 2022, then skyrocketed 1827.7% in 2025.
  • Over 5 years, Retained Earnings stood at $5.8 million in 2021, then crashed by 8148.28% to -$466.8 million in 2022, then increased by 28.02% to -$336.0 million in 2023, then crashed by 60.18% to -$538.2 million in 2024, then skyrocketed by 1619.19% to $8.2 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $8.2 billion, -$166.8 million, and $7.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.